KRAS and non-small cell lung carcinoma: Furthermore, several other targets of mir-27a-3p (MET, EGFR, FOXO1, and KRAS) are reported to have an impact on tumorigenic characteristics of different cancers such as non-small cell lung cancer (MET and EGFR [70]), renal cell carcinoma (EGFR [64]), hepatocellular carcinoma (FOXO1 [71]), and oesophageal carcinoma (KRAS [57]).